Cover Image
市場調查報告書

Dart NeuroScience LLC的產品平台分析

Dart NeuroScience LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 283212
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
Dart NeuroScience LLC的產品平台分析 Dart NeuroScience LLC - Product Pipeline Review - 2015
出版日期: 2015年04月22日 內容資訊: 英文 45 Pages
簡介

Dart NeuroScience LLC是總公司設在美國的生物製藥企業,集中在對記憶障礙有新作用機制的創新藥物的藥物研發及開發。

本報告提供Dart NeuroScience LLC 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Dart NeuroScience LLC 基本資料

  • Dart NeuroScience LLC 概要
  • 主要資訊
  • 企業資料

Dart NeuroScience LLC :R&D概要

  • 主要的治療範圍

Dart NeuroScience LLC :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Dart NeuroScience LLC :開發中產品概況

  • 在臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Dart NeuroScience LLC:藥物簡介

  • HT-0712
  • HT-3951
  • Small Molecule 1 for Cognitive Impairment
  • Small Molecule 1 to Inhibit GlyT-1 for Memory Impairment
  • Small Molecule 1 to Inhibit PDE4 for Memory Impairment
  • Small Molecule 10 for Cognitive Impairment
  • Small Molecule 11 for Cognitive Impairment
  • Small Molecule 12 for Cognitive Impairment
  • Small Molecule 2 for Cognitive Impairment
  • Small Molecule 2 to Inhibit Glyt-1 for Memory Impairment
  • Small Molecule 2 to Inhibit PDE4 for Memory Impairment
  • Small Molecule 3 for Cognitive Impairment
  • Small Molecule 4 for Cognitive Impairment
  • Small Molecule 5 for Cognitive Impairment
  • Small Molecule 6 for Cognitive Impairment
  • Small Molecule 7 for Cognitive Impairment
  • Small Molecule 8 for Cognitive Impairment
  • Small Molecule to Inhibit MAO-B for Memory Impairment
  • Small Molecules to Agonize GABAA Receptor for Cognitive Impairment
  • Small Molecules to Antagonize GALR3 for Memory Impairment

Dart NeuroScience LLC ::開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Dart NeuroScience LLC :最新的開發平台資訊

Dart NeuroScience LLC :開發暫停中的計劃

Dart NeuroScience LLC :開發中止的開發中產品

Dart NeuroScience LLC :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06951CDB

Summary

Global Markets Direct's, 'Dart NeuroScience LLC - Product Pipeline Review - 2015', provides an overview of the Dart NeuroScience LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dart NeuroScience LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Dart NeuroScience LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Dart NeuroScience LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Dart NeuroScience LLC's pipeline products

Reasons to buy

  • Evaluate Dart NeuroScience LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Dart NeuroScience LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Dart NeuroScience LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Dart NeuroScience LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dart NeuroScience LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Dart NeuroScience LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Dart NeuroScience LLC Snapshot
    • Dart NeuroScience LLC Overview
    • Key Information
    • Key Facts
  • Dart NeuroScience LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Dart NeuroScience LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Dart NeuroScience LLC - Pipeline Products Glance
    • Dart NeuroScience LLC - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Dart NeuroScience LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Dart NeuroScience LLC - Drug Profiles
    • HT-0712
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HT-3951
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 1 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 1 to Inhibit GlyT-1 for Memory Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 1 to Inhibit PDE4 for Memory Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 10 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 11 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 12 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 2 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 2 to Inhibit Glyt-1 for Memory Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 2 to Inhibit PDE4 for Memory Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 3 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 4 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 5 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 6 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 7 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 8 for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit MAO-B for Memory Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Agonize GABAA Receptor for Cognitive Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize GALR3 for Memory Impairment
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Dart NeuroScience LLC - Pipeline Analysis
    • Dart NeuroScience LLC - Pipeline Products by Target
    • Dart NeuroScience LLC - Pipeline Products by Route of Administration
    • Dart NeuroScience LLC - Pipeline Products by Molecule Type
    • Dart NeuroScience LLC - Pipeline Products by Mechanism of Action
  • Dart NeuroScience LLC - Recent Pipeline Updates
  • Dart NeuroScience LLC - Dormant Projects
  • Dart NeuroScience LLC - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • HT-2678
  • Dart NeuroScience LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Dart NeuroScience LLC, Key Information
  • Dart NeuroScience LLC, Key Facts
  • Dart NeuroScience LLC - Pipeline by Indication, 2015
  • Dart NeuroScience LLC - Pipeline by Stage of Development, 2015
  • Dart NeuroScience LLC - Monotherapy Products in Pipeline, 2015
  • Dart NeuroScience LLC - Phase II, 2015
  • Dart NeuroScience LLC - Phase I, 2015
  • Dart NeuroScience LLC - Preclinical, 2015
  • Dart NeuroScience LLC - Discovery, 2015
  • Dart NeuroScience LLC - Pipeline by Target, 2015
  • Dart NeuroScience LLC - Pipeline by Route of Administration, 2015
  • Dart NeuroScience LLC - Pipeline by Molecule Type, 2015
  • Dart NeuroScience LLC - Pipeline Products by Mechanism of Action, 2015
  • Dart NeuroScience LLC - Recent Pipeline Updates, 2015
  • Dart NeuroScience LLC - Dormant Developmental Projects,2015
  • Dart NeuroScience LLC - Discontinued Pipeline Products, 2015

List of Figures

  • Dart NeuroScience LLC - Pipeline by Top 10 Indication, 2015
  • Dart NeuroScience LLC - Pipeline by Stage of Development, 2015
  • Dart NeuroScience LLC - Monotherapy Products in Pipeline, 2015
  • Dart NeuroScience LLC - Pipeline by Top 10 Target, 2015
  • Dart NeuroScience LLC - Pipeline by Top 10 Molecule Type, 2015
  • Dart NeuroScience LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top